Skip to content

RDMed

Active
Private limited companyfounded 20223 yrs activeGrand'Route(Flh) 506, 4400 Flémalle, BelgiumKBO/BCE: BE 0791.532.866

RDMed has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €97k and a net result of €68k. Its solvency ranks better than 45% of 19904 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2024
92 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100=
Solvency88▲+26
Growth78
Track record94
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €8k at 30 days acceptable
Liquidity ample (current ratio 3.42 against 1.93 in 2023; short-term debt: 23.4% and cash: 48.4% of total assets), and 36.9% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Five signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 3 years 0 10 y
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-09-2025, 60 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 2 filings
Deviation from the deadline
2025
not confirmed
2024
60 d late
2023
30 d late
← before the deadline after the deadline →
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2024, micro schema

Equity
€97k▲ 209%
2023 · €31k
2023: €31k
2023 → 2024
Total assets
€153k▲ 82.3%
2023 · €84k
2023: €84k
2023 → 2024
Net result
€68k▲ 134%
2023 · €29k
2023: €29k
2023 → 2024
Working capital
€87k▲ 320%
2023 · €21k
2023: €21k
2023 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20232024Trend
Equity€31k-€97k▲ 209%
Operating result€39k-€87k▲ 121%
Net result€29k-€68k▲ 134%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€25k€50k€75kOperating result 2023: €39k€39kNet result 2023: €29k€29kOperating result 2024: €87k€87kNet result 2024: €68k€68k20232024
The operating result rises in 2024; 2024 is 121% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €153k
Fixed assets €31k▼ 25.6%
Current assets €122k▲ 186%
Equity and liabilities €153k
Equity €97k▲ 209%
Debt €57k▲ 7.3%
The debt ratio falls from 62.8% to 36.9%. Equity and debt are higher.
Key figures and ratios
2024 value · change against 2023
EBITDA
€98k
2023 · €50k
Cash flow
€79k
2023 · €40k
Solvency
63.1%
2023 · 37.2%
Current ratio
3.42
2023 · 1.93
Quick ratio
3.42
2023 · 1.93
Debt / equity
0.59
2023 · 1.69
ROE
70.9%
2023 · 93.6%
ROA
44.7%
2023 · 34.8%
Interest coverage
58.20
2023 · 23.17
Debt
€57k
2023 · €53k
Debt ≤ 1 year
€36k
2023 · €22k
Debt > 1 year
€21k
2023 · €31k
Income taxes
€18k
2023 · €8k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet Code20232024
Assets
Total assets20/58€84k€153k
Fixed assets21/28€41k€31k
Tangible fixed assets22/27€41k€31k
Furniture and vehicles24€41k€31k
Current assets29/58€43k€122k
Amounts receivable after more than one year29-€35k
Trade receivables290-€35k
Amounts receivable within one year40/41-€13k
Trade receivables40-€13k
Cash at bank and in hand54/58€42k€74k
Deferred charges and accrued income490/1€957€914
Equity and liabilities
Total equity and liabilities10/49€84k€153k
Equity10/15€31k€97k
Contributions10/11€2k€2k=
Profit (loss) carried forward14€29k€95k
Amounts payable17/49€53k€57k
Amounts payable after more than one year17€31k€21k
Financial debts170/4€31k€21k
Amounts payable within one year42/48€22k€36k
Current portion of amounts payable after more than one year42€9k€10k
Trade debts44€2k€3k
Suppliers440/4€2k€3k
Taxes, remuneration and social security45€8k€19k
Taxes450/3€8k€19k
Other amounts payable47/48€3k€4k
Income statement Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€11k€11k
Other operating charges640/8€1k€285
Gross operating margin9900€51k€98k
Operating profit (loss)9901€39k€87k
Financial income75/76B€0€893
Recurring financial income75€0€893
Financial charges65/66B€2k€2k
Recurring financial charges65€2k€2k
Profit (loss) for the period before taxes9903€37k€87k
Income taxes67/77€8k€18k
Profit (loss) for the period9904€29k€68k
Profit (loss) for the period to be appropriated9905€29k€68k
Appropriation of the result
Profit (loss) to be appropriated9906€29k€98k
Profit (loss) brought forward from the previous period14P-€29k
Profit to be distributed694/7-€3k
Return on contributions (dividend)694-€3k

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2025
29-09
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 60 days late
2024
30-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
NBB filing

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Flémalle · 1 establishment unit since 2022
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Grand'Route(Flh) 5064400 Flémalle
Ground area
91 m²
Building footprint
57 m²
Volume, LiDAR
547 m³
Parcel 62037B0489/00S000, Wallonia · tallest building 10.6 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
RDMed
Grand'Route(Flh) 506, 4400 FlémalleGeneral medical practice
since 20222.336.337.050
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
62037B0489/00S000 Wallonia 91 m² 1 · 57 m² 10.6 m · 3 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 9,116 companies in sector 86210 we hold annual accounts for 6,336. 5,252 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded28-09-2022
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
86220Specialist medical practice
96220Beauty care and other beauty treatments
Sources
Crossroads Bank for EnterprisesNational Bank · 2 filingsAddress and cadastre registers

Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.